JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Follmer, C. H.
Right arrow Articles by Singer, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Follmer, C. H.
Right arrow Articles by Singer, D. H.

Amiodarone-induced block of sodium current in isolated cardiac cells

CH Follmer, M Aomine, JZ Yeh and DH Singer

Department of Pharmacology, Northwestern University Medical School, Chicago, Illinois.

Sodium current (INa) block by amiodarone (AMI) was investigated in isolated single Purkinje and ventricular myocardial cells using the single suction-pipette voltage-clamp technique. AMI produced marked resting block that was enhanced at low holding potentials, findings consistent with a shift in the steady-state INa availability curve to more negative potentials (-16 +/- 3 mV). Resting block was not associated with any change in the time course of INa decay during a depolarizing clamp step. AMI also produced use-dependent block in conjunction with increases in rate (0.5-5.0 Hz) and pulse duration (2- 200 msec). These changes are consistent with a slowing of the recovery from inactivation of the sodium channel. Brief depolarizing pulses produced little use-dependent block, suggesting that the onset of drug- induced block is slow. Thus, AMI blocks INa and shifts the availability curve in isolated myocytes, both of which contribute to the net tonic block. The results suggest that both rested state and inactivated state sodium channel block are factors in AMI's antiarrhythmic efficacy.

Volume 243, Issue 1, pp. 187-194, 10/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
D. Celestino, E. Medei, S. Moro, M. V. Elizari, and S. Sicouri
Acute In Vitro Effects of Dronedarone, an Iodine-Free Derivative, and Amiodarone, on the Rabbit Sinoatrial Node Automaticity: A Comparative Study
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 248 - 257.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
N. Yamashita, T. Kaku, T. Uchino, S. Isomoto, H. Yoshimatsu, and K. Ono
Short- and Long-Term Amiodarone Treatments Regulate Cav3.2 Low-Voltage-Activated T-type Ca2+ Channel through Distinct Mechanisms
Mol. Pharmacol., May 1, 2006; 69(5): 1684 - 1691.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Macianskiene, S. Viappiani, K. R. Sipido, and K. Mubagwa
Slowing of the Inactivation of Cardiac Voltage-Dependent Sodium Channels by the Amiodarone Derivative 2-Methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015)
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Omichi, S. Zhou, M.-H. Lee, A. Naik, C.-M. Chang, A. Garfinkel, J. N. Weiss, S.-F. Lin, H. S. Karagueuzian, and P.-S. Chen
Effects of amiodarone on wave front dynamics during ventricular fibrillation in isolated swine right ventricle
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1063 - H1070.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. G. Cosio and E. Delpon
New Antiarrhythmic Drugs for Atrial Flutter and Atrial Fibrillation: A Conceptual Breakthrough at Last?
Circulation, January 22, 2002; 105(3): 276 - 278.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Aimond, L. Beck, P. Gautier, O. K. Chérif, J.-M. Davy, P. Lorente, D. Nisato, and G. Vassort
Cellular and In Vivo Electrophysiological Effects of Dronedarone in Normal and Postmyocardial Infarcted Rats
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 415 - 424.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
J. Merot, F. Charpentier, J.-M. Poirier, G. Coutris, and J. Weissenburger
Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol
Cardiovasc Res, November 1, 1999; 44(2): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. F. Bosch, G.-R. Li, R. Gaspo, and S. Nattel
Electrophysiologic Effects of Chronic Amiodarone Therapy and Hypothyroidism, Alone and in Combination, on Guinea Pig Ventricular Myocytes
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 156 - 165.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
Fuhua Chen, S. Naim, W. F. Friedman, T. S. Klitzner, and G. T. Wetzel
Age-Dependent Changes in the Effects of Amiodarone on Rabbit Cardiac Myocyte Contractions
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(1): 23 - 32.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. F. Gray, A. S. Mihailidou, P. S. Hansen, K. A. Buhagiar, N. L. Bewick, H. H. Rasmussen, and D. W. Whalley
Amiodarone Inhibits the Na+-K+ Pump in Rabbit Cardiac Myocytes after Acute and Chronic Treatment
J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 75 - 82.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
I. Kodama, K. Kamiya, and J. Toyama
Cellular electropharmacology of amiodarone
Cardiovasc Res, July 1, 1997; 35(1): 13 - 29.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.